Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

News   Mar 05, 2018 | Original story from Owstone Medical

 
Owlstone Medical Raises $15 million USD to Drive Commercialization of its Breath Biopsy Platform

Billy Boyle, CEO, Owlstone Medical

 
 
 

RELATED ARTICLES

Synthetic Material That Detects Enzymatic Activity

News

Scientists integrate protein and polymer building blocks to create stimulus-responsive systems

READ MORE

$26.5M Study on Aggressive Prostate Cancer in African-American Men Begins

News

The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun.

READ MORE

Broadly Acting Antibodies Found in Blood of Ebola Survivors

News

Scientists have discovered a set of powerful, broadly neutralizing antibodies in the blood of Ebola survivors. In animal studies, two of these antibodies provided substantial protection against disease caused by the three species known to cause fatal human illness.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy